Literature DB >> 9575602

The occurrence of Raynaud's phenomenon in a general population: the Framingham Study.

F N Brand1, M G Larson, W B Kannel, J M McGuirk.   

Abstract

The prevalence and predisposing conditions for primary and secondary Raynaud's phenomenon (RP) were examined in The Framingham Study based on 16 years of follow-up of a cohort of 4182 men and women. The association with atypical chest pain and migraine headache was also investigated. Over the 16 years of follow-up there were 130 men and 171 women who developed primary RP. The prevalence in women (9.6%) was somewhat higher than in men (8.1%) and 81.4% of the RP was primary. Secondary RP was equally prevalent in men (18.6%) and women (19.7%). The most common causes of secondary RP were beta-blocker use (34.2%), carpal tunnel syndrome (10.5%) and rheumatoid arthritis (7.2%). Primary RP cases differed from noncases by having lower systolic blood pressure (p < or = 0.001) and diastolic blood pressure (p < 0.0001), and more coronary disease (p = 0.009), smoking (p < or = 0.01) and higher blood sugars (p < or = 0.009). Atypical chest pain was present more often than noted previously in The Framingham Study general population survey, and was equally prevalent in primary and secondary RP and in the two sexes. Associated migraine was more prevalent in women (14.4%) than men (5.0%). Vibrating tool use with associated RP occurred in 14.6%.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9575602     DOI: 10.1177/1358863X9700200404

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  18 in total

Review 1.  Raynaud's phenomenon (primary).

Authors:  Janet Pope
Journal:  BMJ Clin Evid       Date:  2013-10-10

2.  Raynaud's phenomenon: prevalence in an Italian population sample.

Authors:  Rossella De Angelis; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

3.  Vascular acrosyndromes in young adult population. Definition of clinical symptoms and connections to joint hypermobility.

Authors:  Periklis Vounotrypidis; Athina Pyrpasopoulou; Grigorios T Sakellariou; Dimitrios Zisopoulos; Nikoleta Kefala; Dimitrios I Oikonomou; Constantinos Stefanis; Spyros Aslanidis; Charalambos Bermperidis; Periklis Pappas
Journal:  Clin Rheumatol       Date:  2019-06-08       Impact factor: 2.980

Review 4.  Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.

Authors:  Charles Khouri; Thomas Jouve; Sophie Blaise; Patrick Carpentier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-05-31       Impact factor: 4.335

5.  Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic.

Authors:  Catalin M Filipeanu; Ashok K Pullikuth; Jessie J Guidry
Journal:  Mol Pharmacol       Date:  2015-02-13       Impact factor: 4.436

6.  A Randomized Controlled Trial of Acupressure for the Treatment of Raynaud's Phenomenon: The difficulty of conducting a trial in Raynaud's phenomenon.

Authors:  Heather Gladue; Veronica Berrocal; Richard Harris; Pei-Suen Tsou; Gautam Edhayan; Ray Ohara; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-05-02

7.  Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients.

Authors:  Slavica Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Goran L Radunovic; Roksanda M Stojanovic; Dragan Babic
Journal:  Rheumatol Int       Date:  2012-07-22       Impact factor: 2.631

Review 8.  Raynaud's phenomenon (primary).

Authors:  Janet Elizabeth Pope
Journal:  BMJ Clin Evid       Date:  2011-03-14

Review 9.  Raynaud's phenomenon (primary).

Authors:  Janet Elizabeth Pope
Journal:  BMJ Clin Evid       Date:  2008-12-16

Review 10.  International consensus criteria for the diagnosis of Raynaud's phenomenon.

Authors:  Emanual Maverakis; Forum Patel; Daniel G Kronenberg; Lorinda Chung; David Fiorentino; Yannick Allanore; Serena Guiducci; Roger Hesselstrand; Laura K Hummers; Chris Duong; Bashar Kahaleh; Alexander Macgregor; Marco Matucci-Cerinic; Frank A Wollheim; Maureen D Mayes; M Eric Gershwin
Journal:  J Autoimmun       Date:  2014-02-01       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.